close

Enter

Log in using OpenID

Cardiac Resynchronization Therapy Pacemaker Market Size, Share, Analysis and Forecasts 2016 - 2020

embed
According to the report, there is an increase in the incidence of cardiovascular diseases. Cardiovascular diseases such as heart attack, coronary artery disease, cardiomyopathy hypertension, heart arrhythmias, and congenital heart defects can cause
Market Reports Center
One Stop Market Reaserch Shop
Global Cardiac Resynchronization Therapy Pacemaker Market Size,
Share, Global Insights, Analysis and Outlook, Emerging Trends and
Research Report by Market Reports Center
Technavio Announces the Publication of its Research Report – Global Cardiac Resynchronization TherapyPacemaker (CRT-P) Market 2016-2020
Technavio recognizes the following companies as the key players in the Global Cardiac Resynchronization
Therapy-Pacemaker (CRT-P) Market:
BIOTRONIK, Boston Scientific, LivaNova, Medtronic, and St. Jude Medical.
Commenting on the report, an analyst from Technavio’ s team said: “Popularity of robot-assisted cardiac
surgery is a key trend in the market. Robotic technology provides physicians with a better view of the
operative field and easy movement of instruments with precision and control within close-fitting spaces.
These surgeries help reduce the duration of hospital stays, facilitating better cost management. These
procedures also prevent human errors and ensure improved outcomes, reduced recovery periods, and
minimal pain and discomfort.
Browse full report with TOC@ https://marketreportscenter.com/reports/328682/global-cardiacresynchronization-therapy-pacemaker-market-2016-2020
According to the report, there is an increase in the incidence of cardiovascular diseases. Cardiovascular
diseases such as heart attack, coronary artery disease, cardiomyopathy hypertension, heart arrhythmias,
and congenital heart defects can cause heart failures. The incidence of these diseases is rising, with
sudden cardiac arrest being the leading cause of death worldwide among people aged above 40.
Further, the report states that there is a high risk of potential complications in the implantation of CRTPs. Implantation of CRT-Ps at an advanced age is associated with a high probability of mortality. Some
other complications related to CRT-Ps include allergic or physiologic reactions, infections, lead erosion or
Market Reports Center
One Stop Market Reaserch Shop
migration, lead breakage, hematoma or seroma, inaccurate or inability to provide pacing, lead tip
deformation, component failure, and inappropriate detections due to diaphragmatic myopotential
oversensing.
The study was conducted using an objective combination of primary and secondary information including
inputs from key participants in the industry. The report contains a comprehensive market and vendor
landscape in addition to a SWOT analysis of the key vendors.
About Cardiac Resynchronization Therapy-pacemaker (CRT-P)
CRT-Ps are an advanced implantable form of conventional pacemakers. They help the heart function
efficiently by monitoring its signals and coordinating with the ventricles to contract at the same time.
These devices resynchronize the heart's rhythm to improve breathlessness and fatigue, and avoid
dizziness and fainting in individuals.
Physicians surgically implant the CRT-P under the skin, below the collarbone. They connect the electrical
leads through a blood vessel into the heart. Unlike conventional pacemakers, CRT-Ps have two leads: one
placed into the right ventricle and the other in the right atrium. An extra lead is implanted on the left side
of the heart to stimulate the left ventricle, assisting the heart to pump efficiently.
Technavio’ s analysts forecast the global cardiac resynchronization therapy-pacemaker (CRT-P) market to
grow at a CAGR of 8.17% during the period 2016-2020.
Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/328682
Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac resynchronization
therapy-pacemaker (CRT-P) market for 2016-2020. To calculate the market size, the report considers the
revenue generated from the sales of CRT-Ps.
The market is divided into the following segments based on geography:
Americas
EMEA
APAC
Technavio's report, Global Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Market 2016-2020,
has been prepared based on an in-depth market analysis with inputs from industry experts. The report
covers the market landscape and its growth prospects over the coming years. The report also includes a
discussion of the key vendors operating in this market.
Key vendors
BIOTRONIK
Boston Scientific
LivaNova
Medtronic
Market Reports Center
One Stop Market Reaserch Shop
St. Jude Medical
Market driver
Implementation of minimally invasive procedures
For a full, detailed list, view our report
Market challenge
Risk of potential complications
For a full, detailed list, view our report
Market trend
Popularity of robot-assisted cardiac surgery
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’ s time when you purchase this market report. Details are
provided within the report.
To Get Discount On The Report @ https://marketreportscenter.com/request-discount/328682
Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)
[email protected]
Author
thomashartle16
thomashartle16354   documents Email
Document
Category
Health and Medicine
Views
2
File Size
360 KB
Tags
size
1/--pages
Report inappropriate content